United States. General Accounting Office. (1995). Cancer drug research: Contrary to allegation, NIH hydrazine sulfate studies were not flawed : report to the chairman and ranking minority member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight. The Office.
Chicago Style (17th ed.) CitationUnited States. General Accounting Office. Cancer Drug Research: Contrary to Allegation, NIH Hydrazine Sulfate Studies Were Not Flawed : Report to the Chairman and Ranking Minority Member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight. Washington, D.C.: The Office, 1995.
MLA (9th ed.) CitationUnited States. General Accounting Office. Cancer Drug Research: Contrary to Allegation, NIH Hydrazine Sulfate Studies Were Not Flawed : Report to the Chairman and Ranking Minority Member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight. The Office, 1995.